Skip to content
lifestyle.timesla.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ELI LILLY AND COMPANY
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
January 7, 2026
Lilly’s orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial
December 30, 2025
Lilly to participate in J.P. Morgan Healthcare Conference
December 17, 2025
←
Previous Page
1
…
4
5
6